Profile

MD, Ankara University


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Afshar M, Knapp CM, Sarid-Segal O, Devine E, Colaneri LS, Tozier L, Waters ME, Putnam MA, Ciraulo DA. The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. Am J Drug Alcohol Abuse. 2012 Mar; 38(2):181-6.View Related Profiles. PMID: 22221171; PMCID: PMC5377928; DOI: 10.3109/00952990.2011.644002;
     
  2. Litten RZ, Fertig JB, Falk DE, Ryan ML, Mattson ME, Collins JF, Murtaugh C, Ciraulo D, Green AI, Johnson B, Pettinati H, Swift R, Afshar M, Brunette MF, Tiouririne NA, Kampman K, Stout R. A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcohol Clin Exp Res. 2012 Mar; 36(3):406-16.View Related Profiles. PMID: 21950727; PMCID: PMC3248956; DOI: 10.1111/j.1530-0277.2011.01649.x;
     
  3. Knapp CM, Sarid-Segal O, Richardson MA, Colaneri LS, Afshar M, Devine E, Streeter CC, Piechniczek-Buczek J, Ciraulo DA. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):102-5.View Related Profiles. PMID: 20337506; PMCID: PMC4667705; DOI: 10.3109/00952991003674812;
     
  4. Sarid-Segal O, Knapp CM, Burch W, Richardson MA, Bahtia S, DeQuattro K, Afshar M, Richambault C, Sickels L, Devine E, Ciraulo DA. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. Am J Drug Alcohol Abuse. 2009; 35(5):316-9.View Related Profiles. PMID: 19637104; PMCID: PMC4028067; DOI: 10.1080/00952990903060150;
     
  5. Sarid-Segal O, Piechniczek-Buczek J, Knapp C, Afshar M, Devine E, Sickles L, Uwodukunda E, Richambault C, Koplow J, Ciraulo D. The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study. Am J Drug Alcohol Abuse. 2008; 34(4):441-7.View Related Profiles. PMID: 18584574; PMCID: PMC5377927; DOI: 10.1080/00952990802082180;
     
  6. Winhusen T, Somoza E, Sarid-Segal O, Goldsmith RJ, Harrer JM, Coleman FS, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Afshar M, Ciraulo DA, Horn P, Montgomery MA, Elkashef A. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence. Drug Alcohol Depend. 2007 Dec 1; 91(2-3):205-12.View Related Profiles. PMID: 17628352
     
  7. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, Tzilos G, Afshar M, Rouse ED, Tian H, Renshaw PF, Ciraulo DA, Yurgelun-Todd DA. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008 Mar; 33(4):827-36.View Related Profiles. PMID: 17568399
     
  8. Kaufman MJ, Streeter CC, Barros TL, Sarid-Segal O, Afshar M, Tian H, Rouse ED, Foy KK, Brimson ML, Archambault CA, Renshaw PF, Ciraulo DA. Reduced Plasma Nitric Oxide End Products in Cocaine-dependent Men. J Addict Med. 2007 Jun; 1(2):96-103.View Related Profiles. PMID: 21768941; DOI: 10.1097/ADM.0b013e31809a1b6a;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.



Contact for Mentoring: